-
摘要:
目的 小细胞食管癌是一种罕见的食管恶性肿瘤。放化疗已成为局限期小细胞食管癌的主要治疗方法。本研究旨在分析广泛期小细胞食管癌的综合治疗方法及预后。 方法 回顾分析1989年1月至2012年4月天津医科大学肿瘤医院收治的35例广泛期小细胞食管癌患者的临床资料。 结果 本组33例患者获得随访,随访率为94.3%(33/35)。中位生存期9.5(0.6~42.4)个月。35例患者全部发生广泛转移,其中33例初诊时已发生,2例术后确诊。1、2年生存率分别为27.2%(9/33)和9.0%(3/33)。单因素分析显示化疗周期数(≥4)是其生存的危险因素(P=0.02)。多因素分析显示化疗周期数(≥4)是其独立的危险因素(P=0.049)。 结论 广泛期小细胞食管癌恶性程度高且预后不佳。放疗或许不能改善患者的生存。化疗为主的综合治疗是其有效的治疗方法。 Abstract:Objective Small-cell esophageal cancer (SCEC) is a rare malignant tumor. Radiotherapy and chemotherapy have been considered as standard treatments for limited-stage SCEC (LS-SCEC). This study aimed to analyze the comprehensive treatment and prognosis of extensive-stage SCEC (ES-SCEC). Methods We retrospectively analyzed the clinical data of 35 Patients with ES-SCEC from the Cancer Hospital of Tianjin Medical University between January 1989 and April 2012. Results A total of 33 patients (94.3%) participated in follow-up visits. The overall survival of the patients ranged between 0.6 and 42.4 months with a median of 9.5 months. All of the patients suffered from extensive metastasis. Among these patients, 33 manifested metastasis at diagnosis and 2 showed metastasis after surgery. One- and two-year survival rates were 27.2% (9/33) and 9.0% (3/33), respectively. Univariate and multivariate analysis results revealed that the number of chemotherapy cycles (≥4) is a risk factor of OS (P=0.02) and the only independent risk factor (P=0.049). Conclusion ES-SCEC is a malignant tumor with poor prognosis. Radiotherapy could not improve patient survival. Chemotherapy combined other therapeutic procedures could be considered as an effective treatment. -
Key words:
- small-cell esophageal cancer /
- radiotherapy /
- chemotherapy
-
表 1 影响广泛期小细胞食管癌33例患者预后的单因素分析
Table 1. Univariate analyses of the prognosis of 33 patients with ES-SCEC
-
[1] Kuo CH, Hsieh CC, Chan ML, et al. Small cell carcinoma of the esophagus: a report of 16 cases from a single institution and literature review[J]. Ann Thorac Surg, 2011, 91(2):373-378. doi: 10.1016/j.athoracsur.2010.09.030 [2] Lu J, Xue LY, Lu N, et al. Superficial primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical analysis of 15 cases[J]. Dis Esophagus, 2010, 23(2):153-159. doi: 10.1111/j.1442-2050.2009.00981.x [3] Lu XJ, Luo JD, Ling Y, et al. Management of small cell carcinoma of esophagus in china[J]. J Gastrointest Surg, 2013, 17(7):1181-1187. doi: 10.1007/s11605-013-2204-7 [4] Kawamura N, Ogasawara N, Utsumi K, et al. Long-term survival and improved quality of life after chemoradiotherapy to treat esophageal small cell carcinoma: a report of two cases[J]. Hepatogastroenterology, 2011, 58(110-111):1588-1594. http://cn.bing.com/academic/profile?id=a165d8ce1357494e3c5c28d4a90422e8&encoded=0&v=paper_preview&mkt=zh-cn [5] Nakajima Y, Zenda S, Minashi K, et al. Non-surgical approach to small cell carcinoma of the esophagus: does this rare disease have the same tumor behavior as SCLC[J]? Int J Clin Oncol, 2012, 17(6): 610-615. doi: 10.1007/s10147-011-0332-1 [6] Meng MB, Zaorsky NG, Jiang C, et al. Radiotherapy and chemotherapy are associated with improved outcomes over surgery and chemotherapy in the management of limited-stage small cell esophageal carcinoma[J]. Radiother Oncol, 2013, 106(3):317-322. [7] Usami S, Motoyama S, Maruyama K. et al. Small cell carcinoma of the esophagus treated with esophagectomy and following chemotherapy: case Report with review of the literature[J]. European Surgical Research, 2010, 45(1):41-44. http://cn.bing.com/academic/profile?id=d1572c90cef1f33096bf6fe694d7f810&encoded=0&v=paper_preview&mkt=zh-cn [8] Raja S, Rice TW, Rajeswaran J, et al. Esophageal small-cell cancer: study of a rare disease[J]. Dis Esophagus, 2013, 26(7):690-695. http://cn.bing.com/academic/profile?id=b7cd22f8a4839ad7c95b593ab57d891f&encoded=0&v=paper_preview&mkt=zh-cn [9] 赵华锋, 赵锡江, 唐鹏, 等.原发性食管小细胞癌的诊疗及预后[J].天津医科大学学报.2007, 13(3): 337-389. doi: 10.3969/j.issn.1006-8147.2007.03.024Zhao HF, Zhao XJ, Tang P, et al. Diagnosis and prognosis of primary esophageal small cell carcinoma[J]. Journal of Tianjin Medical University, 2007, 13(3):337-389. doi: 10.3969/j.issn.1006-8147.2007.03.024 [10] 宋岩, 王绿化, 郝捷, 等.151例食管小细胞癌的治疗与预后分析[J].癌症, 2009, 28(3):303-307. doi: 10.3321/j.issn:1000-467X.2009.03.014Song Y, Wang LH, Hao J, et al. Treatment and prognosis of 151 cases of small cell carcinoma of the esophagus[J]. Ai Zheng, 2009, 28 (3):303-207. doi: 10.3321/j.issn:1000-467X.2009.03.014 [11] Al Mansoor S, Ziske C, Schmidt-Wolf IG, et al. Primary small cell carcinoma of esophagus: patient data meta analysis and review of the literature[J]. Ger Med Sci, 2013, doi: 10.3205/000180. [12] Hudson E, Powell J, Mukherjee S, et al. Small cell oesophageal carcinoma: an institutional experience and review of the literature[J]. Br J Cancer, 2007, 96(5):708-711. doi: 10.1038/sj.bjc.6603611 [13] Gao R, Zhang Y, Wen XP, et al. Chemotherapy with cisplatin or carboplatin in combination with etoposide for small-cell esophageal cancer: a systemic analysis of case series[J]. Dis Esophagus, 2013, doi: 10.1111/dote.12149. [14] Atsumi K, Shioyama Y, Nomoto S. et al. Chemoradiation for Small Cell Esophageal Carcinoma: Report of 11 Cases from Multi-institution Experience[J]. J Radiat Res, 2010, 51(1):15-20. doi: 10.1269/jrr.09074 [15] Mizuuchi Y, Anbe K, Yamagata N. et al. A case of stage IVb small cell carcinoma of the esophagus obtained prolonged survival after combined modality therapy[J]. Gan To Kagaku Ryoho, 2010, 37(4): 715-718. http://cn.bing.com/academic/profile?id=0b083672e0a7d10aa547143bd7b24550&encoded=0&v=paper_preview&mkt=zh-cn [16] Brenner B, Tang LH, Klimstra DS, et al. Small-cell carcinomas of the gastrointestinal tract:a review[J]. J Clin Oncol, 2004, 22(13):2730-2739. doi: 10.1200/JCO.2004.09.075 [17] Zhu Y, Qiu B, Liu H. et al. Primary small cell carcinoma of the esophagus: review of 64 cases from a single institution[J]. Dis Esophagus, 2013, 27(2):152-158. http://cn.bing.com/academic/profile?id=d21929e4dea37db7d7d8063a7e45d8c0&encoded=0&v=paper_preview&mkt=zh-cn